Psychiatric aspects in Parkinsonism treated with L-dopa

J Neurol Neurosurg Psychiatry. 1971 Oct;34(5):502-7. doi: 10.1136/jnnp.34.5.502.

Abstract

Psychiatric aspects of patients with Parkinsonism treated with L-dopa are described. These include acute psychosis in patients with or without previous psychiatric illness and worsening or improvement of pre-existing psychiatric conditions. Therapeutic management is discussed The relevance of these studies to the understanding of the psychiatric aspects of Parkinsonism in general is discussed.

MeSH terms

  • Affect
  • Aged
  • Antidepressive Agents / therapeutic use
  • Anxiety
  • Arousal
  • Barbiturates / therapeutic use
  • Cognition Disorders / chemically induced
  • Depression / chemically induced
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects*
  • Dihydroxyphenylalanine / therapeutic use
  • Drug Antagonism
  • Drug Interactions
  • Female
  • Hallucinations / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Neurotic Disorders / chemically induced*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Psychoses, Substance-Induced / etiology*
  • Psychotherapy
  • Sleep
  • Tranquilizing Agents / therapeutic use
  • Vision, Ocular

Substances

  • Antidepressive Agents
  • Barbiturates
  • Tranquilizing Agents
  • Dihydroxyphenylalanine